• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Clinical analysis of 23 patients pathologically diagnosed with primary and secondary pulmonary enteric adenocarcinoma.23 例原发性和继发性肺肠型腺癌病理诊断的临床分析。
Chin Med J (Engl). 2019 Jun 5;132(11):1368-1369. doi: 10.1097/CM9.0000000000000266.
2
KRAS Mutation for Staging Resected Non-Small Cell Lung Cancer.用于分期切除的非小细胞肺癌的KRAS突变
J Thorac Oncol. 2019 Jul;14(7):e153-e155. doi: 10.1016/j.jtho.2019.02.023.
3
Clonality assessment of multifocal lung adenocarcinoma by pathology evaluation and molecular analysis.通过病理评估和分子分析评估多灶性肺腺癌的克隆性。
Hum Pathol. 2018 Nov;81:261-271. doi: 10.1016/j.humpath.2018.01.030. Epub 2018 Jul 3.
4
Molecular analysis of peripheral lung adenocarcinoma in brush cytology obtained by EBUS plus fluoroscopy-guided bronchoscopy.经 EBUS 加透视引导支气管镜刷取的外周型肺腺癌的分子分析。
Cancer Cytopathol. 2018 Oct;126(10):860-871. doi: 10.1002/cncy.22053. Epub 2018 Oct 6.
5
Clinicopathological, immunohistochemical, and mutational analyses of pulmonary enteric adenocarcinoma: usefulness of SATB2 and β-catenin immunostaining for differentiation from metastatic colorectal carcinoma.肺肠型腺癌的临床病理、免疫组化及突变分析：SATB2和β-连环蛋白免疫染色在与转移性结直肠癌鉴别诊断中的应用
Hum Pathol. 2017 Jun;64:179-185. doi: 10.1016/j.humpath.2017.04.006. Epub 2017 Apr 21.
6
[Synchronous pulmonary adenocarcinoma and primary lymphoma of lung mucosa-associated lymphoid tissue].[同步性肺腺癌与肺黏膜相关淋巴组织原发性淋巴瘤]
Medicina (B Aires). 2019;79(3):208-211.
7
Comparison of CT radiogenomic and clinical characteristics between EGFR and KRAS mutations in lung adenocarcinomas.肺腺癌中EGFR和KRAS突变之间的CT放射基因组学与临床特征比较
Clin Radiol. 2018 Jun;73(6):590.e1-590.e8. doi: 10.1016/j.crad.2018.01.009. Epub 2018 Feb 14.
8
Pulmonary adenocarcinoma with enteric differentiation: Dissecting oncogenic genes alterations with DNA sequencing and FISH analysis.具有肠化生的肺腺癌：通过DNA测序和FISH分析剖析致癌基因改变
Exp Mol Pathol. 2017 Apr;102(2):276-279. doi: 10.1016/j.yexmp.2017.02.014. Epub 2017 Feb 22.
9
Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.年轻肺腺癌患者致癌基因改变的独特患病率。
Cancer. 2017 May 15;123(10):1731-1740. doi: 10.1002/cncr.30539. Epub 2017 Feb 8.
10
Detection of synchronous primary lung adenocarcinomas with genomic sequencing.通过基因组测序检测同步性原发性肺腺癌
Ann Diagn Pathol. 2018 Jun;34:42-44. doi: 10.1016/j.anndiagpath.2018.01.007. Epub 2018 Jan 11.

引用本文的文献

1
Case Report: Controversies in managing pulmonary enteric adenocarcinoma: reflections from an early-stage case.病例报告：肺肠型腺癌管理中的争议：来自一例早期病例的思考
Front Oncol. 2025 Jun 17;15:1603084. doi: 10.3389/fonc.2025.1603084. eCollection 2025.
2
Lung enteric-type adenocarcinoma with gastric metastasis: a rare case report and literature review.肺肠型腺癌伴胃转移：一例罕见病例报告及文献复习。
Front Immunol. 2024 Oct 23;15:1486214. doi: 10.3389/fimmu.2024.1486214. eCollection 2024.
3
Case report: F-FDG PET/CT in pulmonary enteric adenocarcinoma.病例报告：18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在肺肠型腺癌中的应用
Front Oncol. 2024 Oct 14;14:1447453. doi: 10.3389/fonc.2024.1447453. eCollection 2024.
4
Primary pulmonary enteric adenocarcinoma presenting as a solitary skull mass.原发性肺肠型腺癌表现为单发颅骨肿块。
BMJ Case Rep. 2024 Jan 18;17(1):e258535. doi: 10.1136/bcr-2023-258535.
5
Lymph node and bone metastasis of pulmonary intestinal adenocarcinoma: A case report.肺肠腺癌的淋巴结及骨转移：一例报告
Oncol Lett. 2023 Sep 27;26(5):488. doi: 10.3892/ol.2023.14075. eCollection 2023 Nov.
6
Clinical features and prognosis of pulmonary enteric adenocarcinoma: A retrospective study in China and the SEER database.肺肠型腺癌的临床特征与预后：一项基于中国及监测、流行病学和最终结果（SEER）数据库的回顾性研究
Front Oncol. 2023 Mar 27;13:1099117. doi: 10.3389/fonc.2023.1099117. eCollection 2023.
7
A case report of pulmonary combined small cell carcinoma with enteric adenocarcinoma.肺小细胞癌合并肠腺癌一例报告
Transl Cancer Res. 2022 Oct;11(10):3890-3894. doi: 10.21037/tcr-22-1171.
8
Hyperprogressive Disease After Immunotherapy: A Case Report of Pulmonary Enteric Adenocarcinoma.免疫治疗后出现的超进展性疾病：一例肺肠腺癌病例报告
Front Oncol. 2022 Mar 7;12:799549. doi: 10.3389/fonc.2022.799549. eCollection 2022.
9
Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma.肺肠型腺癌的基因突变谱和免疫微环境分析。
Diagn Pathol. 2022 Feb 16;17(1):30. doi: 10.1186/s13000-022-01206-7.
10
Pulmonary enteric adenocarcinoma: a literature review.肺肠型腺癌：文献综述
J Thorac Dis. 2020 Jun;12(6):3217-3226. doi: 10.21037/jtd-19-4171.

本文引用的文献

1
Distinctive features of immunostaining and mutational load in primary pulmonary enteric adenocarcinoma: implications for differential diagnosis and immunotherapy.原发性肺肠型腺癌的免疫组化和突变负荷特征：对鉴别诊断和免疫治疗的影响。
J Transl Med. 2018 Mar 27;16(1):81. doi: 10.1186/s12967-018-1449-z.
2
Scientific Advances in Lung Cancer 2015.2015 年肺癌的科学进展。
J Thorac Oncol. 2016 May;11(5):613-638. doi: 10.1016/j.jtho.2016.03.012. Epub 2016 Mar 22.
3
The prevalence and prognostic significance of KRAS mutation subtypes in lung adenocarcinomas from Chinese populations.中国人群肺腺癌中KRAS突变亚型的患病率及预后意义。
Onco Targets Ther. 2016 Feb 22;9:833-43. doi: 10.2147/OTT.S96834. eCollection 2016.
4
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.2015 年世界卫生组织肺肿瘤分类：自 2004 年分类以来遗传、临床和放射学进展的影响。
J Thorac Oncol. 2015 Sep;10(9):1243-1260. doi: 10.1097/JTO.0000000000000630.
5
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary.国际肺癌研究协会/美国胸科学会/欧洲呼吸学会：肺腺癌国际多学科分类：执行摘要。
Proc Am Thorac Soc. 2011 Sep;8(5):381-5. doi: 10.1513/pats.201107-042ST.

23 例原发性和继发性肺肠型腺癌病理诊断的临床分析。

Clinical analysis of 23 patients pathologically diagnosed with primary and secondary pulmonary enteric adenocarcinoma.

机构信息

Graduate College of Fujian Medical University, Fuzhou, Fujian 350025, China.

Pathology Department, The 900th Hospital of the Joint Logistic Support Force, People's Liberation Army, Fujian Medical University, Fuzhou, Fujian 350025, China.

出版信息

Chin Med J (Engl). 2019 Jun 5;132(11):1368-1369. doi: 10.1097/CM9.0000000000000266.

DOI:10.1097/CM9.0000000000000266
PMID:31021978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6629350/
Abstract

Supplemental Digital Content is available in the text

摘要

补充数字内容可在文本中找到